ATE457779T1 - Metallorganische komplexe auf manganbasis, pharmazeutische zusammensetzungen und diätetische produkte - Google Patents

Metallorganische komplexe auf manganbasis, pharmazeutische zusammensetzungen und diätetische produkte

Info

Publication number
ATE457779T1
ATE457779T1 AT04715267T AT04715267T ATE457779T1 AT E457779 T1 ATE457779 T1 AT E457779T1 AT 04715267 T AT04715267 T AT 04715267T AT 04715267 T AT04715267 T AT 04715267T AT E457779 T1 ATE457779 T1 AT E457779T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
manganeous
compounds
dietary products
organometal complexes
Prior art date
Application number
AT04715267T
Other languages
English (en)
Inventor
Jean-Claude Maurel
Claude-Alain Cudennec
Original Assignee
Medesis Pharma S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medesis Pharma S A filed Critical Medesis Pharma S A
Application granted granted Critical
Publication of ATE457779T1 publication Critical patent/ATE457779T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04715267T 2003-02-28 2004-02-27 Metallorganische komplexe auf manganbasis, pharmazeutische zusammensetzungen und diätetische produkte ATE457779T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03290491A EP1452175A1 (de) 2003-02-28 2003-02-28 Organometallische Komplexe entahltend Mangan, pharmazeutische Formulierungen und Diätetika
PCT/EP2004/001961 WO2004075990A1 (en) 2003-02-28 2004-02-27 Manganese based organometallic complexes, pharmaceutical compositions and dietetic products

Publications (1)

Publication Number Publication Date
ATE457779T1 true ATE457779T1 (de) 2010-03-15

Family

ID=32748999

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04715267T ATE457779T1 (de) 2003-02-28 2004-02-27 Metallorganische komplexe auf manganbasis, pharmazeutische zusammensetzungen und diätetische produkte

Country Status (8)

Country Link
US (2) US20060128678A1 (de)
EP (2) EP1452175A1 (de)
JP (1) JP2006520752A (de)
AT (1) ATE457779T1 (de)
AU (1) AU2004216473B2 (de)
CA (1) CA2517370C (de)
DE (1) DE602004025557D1 (de)
WO (1) WO2004075990A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452175A1 (de) * 2003-02-28 2004-09-01 Medesis Pharma S.A. Organometallische Komplexe entahltend Mangan, pharmazeutische Formulierungen und Diätetika
EP1652512A1 (de) * 2004-11-02 2006-05-03 Medesis Pharma Umkehrmizellen-Zusammensetzung zur Verabreichung von Metallkationen enthaltend einen Diglycerid und einen Phytosterol und Verfahren zur Herstellung
PT2550020E (pt) 2010-03-24 2015-10-20 Medesis Pharma Microemulsão de micelas reversas compreendendo iões metálicos e sua utilização
US10155783B2 (en) 2013-05-28 2018-12-18 Merck Patent Gmbh Manganese complexes and use thereof for preparing thin films
JP6113133B2 (ja) 2014-11-06 2017-04-12 日本メナード化粧品株式会社 幹細胞の未分化状態維持剤及び増殖促進剤
CN112691120B (zh) * 2019-10-23 2022-03-29 北京大学 二价锰在制备免疫增强药物或抗肿瘤药物中的应用
CN113061259B (zh) * 2021-03-14 2022-03-29 华中科技大学同济医学院附属协和医院 用于缺血性脑卒中治疗的金属有机框架材料的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE209928T1 (de) * 1992-09-09 2001-12-15 Bio Technology General Corp Verwendung von mangan-superoxiddismutase (mn-sod) zur herstellung von arzneimitteln zur behandlung von erkrankungen in niedriger dosierung
JPH07126176A (ja) * 1993-06-15 1995-05-16 Hiroshi Sakurai 活性酸素抑制剤
FR2729957B1 (fr) * 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
FR2750606B1 (fr) * 1996-07-03 1999-01-29 Maurel Sante Complexes organometalliques a base de sitosterols et de diglycerides et compositions pharmaceutiques en contenant
US5715143A (en) * 1996-07-22 1998-02-03 Delco Electronics Corporation Carrier system for integrated circuit carrier assemblies
ATE552260T1 (de) * 1999-01-25 2012-04-15 Nat Jewish Health Substituierte porphyrine und deren therapeutische verwendung
JP2000247978A (ja) * 1999-02-25 2000-09-12 Toyo Ink Mfg Co Ltd 金属ポルフィリン錯体及びそれを含有してなる医薬組成物
GB2368521B (en) * 2000-10-31 2004-12-08 Jasali Ltd Pharmaceutical or dietary composition containing a vegetable oil in particular olive oil and sitosterol
EP1439842A4 (de) * 2001-06-01 2009-09-02 Nat Jewish Med & Res Center Oxidantienfänger zur behandlung von diabetes oder zur verwendung bei der transplantation oder induktion von immuntoleranz
EP1452175A1 (de) * 2003-02-28 2004-09-01 Medesis Pharma S.A. Organometallische Komplexe entahltend Mangan, pharmazeutische Formulierungen und Diätetika

Also Published As

Publication number Publication date
EP1606021A1 (de) 2005-12-21
US20060128678A1 (en) 2006-06-15
EP1452175A1 (de) 2004-09-01
AU2004216473A1 (en) 2004-09-10
AU2004216473B2 (en) 2009-05-07
CA2517370A1 (en) 2004-09-10
DE602004025557D1 (de) 2010-04-01
JP2006520752A (ja) 2006-09-14
WO2004075990A1 (en) 2004-09-10
US20090247492A1 (en) 2009-10-01
CA2517370C (en) 2012-02-07
EP1606021B1 (de) 2010-02-17

Similar Documents

Publication Publication Date Title
WO2009050506A3 (en) Combination 059
CY1110353T1 (el) Ανοσορρυθμιστικοι ολιγοσακχαριτες
CY1108514T1 (el) Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων
WO2004065423A3 (de) Erkennungsmoleküle zur behandlung und detektion von tumoren
DE60216139D1 (de) Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen
EP1623046A4 (de) Zusammensetzungen und verfahren zur behandlung von schwerem akutem respiratorischem syndrom (sars)
MX337100B (es) Compuestos alcoxi para el tratamiento de enfermedades.
MXPA05009595A (es) Compuestos 7-amino-isoindolilo y sus usos farmaceuticos.
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
BR112022018645A2 (pt) Composições e métodos para tratar ou prevenir doenças inflamatórias, incluindo diabetes mellitus tipo i e tipo ii e doenças da tireoide
WO2008013986A3 (en) Compositions and methods for treating or preventing ophthalmic light toxicity
ATE456955T1 (de) Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen
WO2008157747A8 (en) Use of inhibition of exonuclease 1 in methods for therapy and diagnostic of neurodegenerative diseases, eye diseases, and mitochondrial disorders
ATE457779T1 (de) Metallorganische komplexe auf manganbasis, pharmazeutische zusammensetzungen und diätetische produkte
CR8696A (es) Beta-carbolinas utiles para tratar enfermedades inflamatorias
WO2007132292A3 (en) Therapy for alzheimer's disease
WO2010031708A3 (en) Ortho-aminoanilides for the treatment of cancer
WO2005074887A3 (en) Amphiphilic star-like or scorpion-like macromolecules, various compositions and uses thereof
WO2007071658A3 (de) Novel alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
WO2005016267A3 (en) Oxazole compounds for the treatment of neurodegenerative disorders
BRPI0509477A (pt) compostos de sulfonamida para o tratamento de distúrbios neurodegenerativos
BRPI0509559A (pt) compostos de pirazolamina para o tratamento de distúrbios neurodegenerativos
WO2007006521A3 (en) Nutritional mixtures with a high and increased efficacy
ATE399758T1 (de) Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties